# EDGAR Filing Document

**Accession Number:** 0001386301
**File Stem:** 0001104659-23-017587
**Filing Date:** 2023-2
**Character Count:** 28236
**Document Hash:** 6734bb8ed29c43efd928856b05281663
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001104659-23-017587.hdr.sgml**: 20230209

**ACCESSION NUMBER**: 0001104659-23-017587

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 14

**CONFORMED PERIOD OF REPORT**: 20230209

**ITEM INFORMATION**: Results of Operations and Financial Condition

**ITEM INFORMATION**: Financial Statements and Exhibits

**FILED AS OF DATE**: 20230209

**DATE AS OF CHANGE**: 20230209

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Research Solutions, Inc.
- **CENTRAL INDEX KEY:** 0001386301
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-BUSINESS SERVICES, NEC [7389]
- **IRS NUMBER:** 000000000
- **STATE OF INCORPORATION:** NV
- **FISCAL YEAR END:** 0630

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-39256
- **FILM NUMBER:** 23606379

**BUSINESS ADDRESS:**
- **STREET 1:** 10624 S. EASTERN AVE
- **STREET 2:** SUITE A-614
- **CITY:** HENDERSON
- **STATE:** NV
- **ZIP:** 89052
- **BUSINESS PHONE:** 310 477 0354

**MAIL ADDRESS:**
- **STREET 1:** 10624 S. EASTERN AVE
- **STREET 2:** SUITE A-614
- **CITY:** HENDERSON
- **STATE:** NV
- **ZIP:** 89052

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Derycz Scientific Inc
- **DATE OF NAME CHANGE:** 20070112

?xml version="1.0" encoding="utf-8"?

**UNITED STATES SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**FORM 8-K**

**CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934**

Date of Report:

(Date of earliest event reported)

**February 9, 2023**

**Research Solutions, Inc.**

(Exact name of registrant as specified in its charter)

**Nevada**

(State or other Jurisdiction of Incorporation)

---

| | |
|:---|:---|
| &nbsp;&nbsp; **1-39256** | &nbsp;&nbsp;**11-3797644** |
| &nbsp;&nbsp;(Commission File Number) | &nbsp;&nbsp;(IRS Employer Identification No.) |

---

**N/A**

(Address of Principal Executive Offices and zip code)

**(310) 477-0354**

(Registrant's telephone number, including area code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of registrant under any of the following provisions:

◻ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

◻ Soliciting material pursuant to Rule 14a-12(b) under the Exchange Act (17 CFR 240.14a-12(b))

◻ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

◻ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| &nbsp;&nbsp;<u>Title of each Class</u> | &nbsp;&nbsp;<u>Trading Symbol(s)</u> | &nbsp;&nbsp;<u>Name of each Exchange on which registered</u> |
| &nbsp;&nbsp;Common stock, $0.001 par value | &nbsp;&nbsp;RSSS | &nbsp;&nbsp;The Nasdaq Stock Market LLC |

---

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR 230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR 240.12b-2).

Emerging growth company&nbsp;&nbsp;&nbsp;&nbsp; ◻

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &nbsp;&nbsp;&nbsp;&nbsp; ◻

---

| | |
|:---|:---|
| **Item 2.02.** | **Results of Operations and Financial Condition.** |

---

On February 9, 2023, the Registrant announced its financial results for the second quarter ended December 31, 2022. A copy of the press release is being furnished as Exhibit 99.1 to this Current Report on Form 8-K.

The information in this Item 2.02 and Exhibit 99.1 attached hereto is intended to be furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 (the "Exchange Act") or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act except as expressly set forth by specific reference in such filing.

---

| | |
|:---|:---|
| **Item 9.01.** | **Financial Statements and Exhibits** |

---

(d) Exhibits.

---

| | |
|:---|:---|
| Exhibit Number | Description |
| [99.1](tm236092d1_ex99-1.htm) | [Press Release issued February 9, 2023 entitled "Research Solutions Reports Fiscal Second Quarter 2023 Results".](tm236092d1_ex99-1.htm) |
| 104 | Cover Page Interactive Data File (embedded as Inline XBRL document) |

---

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

---

| | | |
|:---|:---|:---|
|  | **RESEARCH SOLUTIONS, INC.** | **RESEARCH SOLUTIONS, INC.** |
| Date: February 9, 2023 | By: | /s/ William Nurthen |
|  |  | William Nurthen |
|  |  | Chief Financial Officer |

---

## Exhibit 99.1

**Exhibit 99.1**

**FOR IMMEDIATE RELEASE**

![](tm236392d1_ex99-1img01.jpg)

**Research Solutions Reports Fiscal Second Quarter 2023 Results**

*Reports 10.7% Total Revenue and 31% Platform Revenue Growth, Increase in ARR to $8.8 Million*

 

**HENDERSON, Nev., February 9, 2023** — **Research Solutions, Inc.** (NASDAQ: RSSS), a pioneer in providing cloud-based workflow solutions for R&D driven organizations, reported financial results for its fiscal second quarter ended December 31, 2022.

**Fiscal Second Quarter 2023 Summary**

&nbsp;&nbsp;&nbsp;&nbsp;· Total
 revenue of $8.7 million, a 10.7% increase from prior-year quarter representing the Company's
 second consecutive quarter of double-digit revenue growth

&nbsp;&nbsp;&nbsp;&nbsp;· Platform
 revenue up 31% to $2.1 million. Annual Recurring Revenue ("ARR") up 28%
 to $8.8 million

&nbsp;&nbsp;&nbsp;&nbsp;· Gross
 profit up 20% from prior-year quarter. Total gross margin improved 300 basis points to 39.0%

&nbsp;&nbsp;&nbsp;&nbsp;· Loss
 of $0.01 per share, compared to a loss of $0.02 per share in the prior-year quarter

&nbsp;&nbsp;&nbsp;&nbsp;· Positive
 Adjusted EBITDA of $201,000 compared to loss of $165,000 in the prior-year quarter

&nbsp;&nbsp;&nbsp;&nbsp;· Positive
 cash flow from operations of $0.9 million for the quarter and $1.0 million fiscal year to
 date, compared to negative cash flow from operations of $0.3 million in the same fiscal year
 to date period in the prior-year

"Our second quarter results reflect the ongoing strength of our business, including the adoption of our Platform by new customers and the second consecutive quarter of revenue growth in our Transactions business," said Roy W. Olivier, President and CEO of Research Solutions. "The increase in ARR during the quarter reflects the onboarding of new customers, expanded use of the Platform by existing customers including upgrades, and our new Curedatis offering introduced during the quarter. We believe our products deliver a solid return on investment to our customers and we continue to maintain good retention and positive upsell momentum in the present economic environment. While onboarding new customers has proved more challenging in recent quarters, I remain confident in the long-term growth prospects of our Platforms offering and our ability to attract and retain new customers."

**Fiscal Second Quarter 2023 Results**

Total revenue was $8.7 million, a 10.7% increase from $7.9 million in the year-ago quarter as both platform and transaction revenue increased from the prior period.

Platform subscription revenue increased 31% to $2.1 million compared to $1.6 million in the year-ago quarter. The increase was primarily due to an increase in the total number of paid Platform deployments, including 34 net deployments added in the quarter, as well as upsells to existing customers. The quarter ended with annual recurring revenue of $8.8 million, up 28% year-over-year (see the company's definition of annual recurring revenue below).

Transaction revenue was $6.6 million, compared to $6.3 million the second quarter of fiscal 2022. After historically being flat to down due to customer savings generated by the Platform, the Company has now experienced two consecutive quarters of transaction revenue growth. This growth does not include any impacts of the previously announced Fiz transaction, which will begin to contribute to the business in the fiscal third quarter. Transaction customer count for the quarter was 1,223, compared to 1,179 customers in the prior-year quarter (see the company's definition of active customer accounts and transactions below).

Total gross margin improved 300 basis points from the prior-year quarter to 39.0%. The increase was primarily driven by a continued revenue mix shift to the higher-margin Platform business which now constitutes approximately 24% of the Company's revenue and generates a majority of its gross profit.

Total operating expenses were $3.7 million, compared to $3.3 million in the second quarter of 2022. The increase was primarily due to non-cash stock compensation expense associated with the valuation of the Company's Long Term Equity Bonus ("LTEBP") program. The LTEBP replaces the prior restricted stock program for executives and attempts to better align executive compensation with stockholder interests through the provision of restricted stock grants that only vest if certain stock price thresholds are attained which range between $3.00 and $6.00 per share. More information on the LTEBP can be found in our quarterly Form 10-Q filing.

Net loss in the second quarter was ($256,000), or ($0.01) per share, compared to net loss of ($482,000), or ($0.02) per share, in the prior-year quarter. Removing the impact of the additional expense associated with the LTEBP, the net loss for the Company in the quarter would be roughly break-even. Adjusted EBITDA was $201,000, compared to a loss of $165,000 in the year-ago quarter (see definition and further discussion about the presentation of Adjusted EBITDA, a non-GAAP term, below).

**Conference Call**

Research Solutions President and CEO Roy W. Olivier and CFO Bill Nurthen will host the conference call, followed by a question and answer period.

Date: Thursday, February 9, 2023

Time: 5:00 p.m. ET (2:00 p.m. PT)

Dial-in number: 1-631-891-4304

Conference ID: 10020971

The conference call will be broadcast live and available for replay until March 9, 2023 by dialing 1-412-317-6671 and using the replay ID 10020971, and via the investor relations section of the company's website at <u>http://researchsolutions.investorroom.com/</u>.

**Fiscal Second Quarter Financial and Operational Summary Tables vs. Prior-Year Quarter**

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **Quarter Ended December 31,** | **Quarter Ended December 31,** | **Quarter Ended December 31,** | **Quarter Ended December 31,** | **Six Months Ended December 31,** | **Six Months Ended December 31,** | **Six Months Ended December 31,** | **Six Months Ended December 31,** |
|  | **2022** | **2021** | **Change** | **% Change** | **2022** | **2021** | **Change** | **% Change** |
| Revenue: |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Platforms | $2110272 | $1604829 | $505443 | 31.5% | $4130239 | $3114703 | $1015536 | 32.6% |
| &nbsp;&nbsp;&nbsp;Transactions | $6606394 | $6267458 | 338936 | 5.4% | $13271070 | $12500088 | 770982 | 6.2% |
| Total Revenue | 8716666 | 7872287 | 844379 | 10.7% | 17401309 | 15614791 | 1786518 | 11.4% |
| Gross Profit: |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Platforms | 1857199 | 1373161 | 484038 | 35.2% | 3646693 | 2637379 | 1009314 | 38.3% |
| &nbsp;&nbsp;&nbsp;Transactions | 1546628 | 1464499 | 82129 | 5.6% | 3106382 | 2860656 | 245726 | 8.6% |
| Total Gross Profit | 3403827 | 2837660 | 566167 | 20.0% | 6753075 | 5498035 | 1255040 | 22.8% |
| Gross profit as a % of revenue: |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Platforms | 88.0% | 85.6% | 2.4% |  | 88.3% | 84.7% | 3.6% |  |
| &nbsp;&nbsp;&nbsp;Transactions | 23.4% | 23.4% | 0.0% |  | 23.4% | 22.9% | 0.5% |  |
| Total Gross Profit | 39.0% | 36.0% | 3.0% |  | 38.8% | 35.2% | 3.6% |  |
| Operating Expenses: |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Sales and marketing | 666608 | 518357 | 148251 | 28.6% | 1187824 | 1041308 | 146516 | 14.1% |
| &nbsp;&nbsp;&nbsp;Technology and product development | 922132 | 868236 | 53896 | 6.2% | 1797422 | 1689696 | 107726 | 6.4% |
| &nbsp;&nbsp;&nbsp;General and administrative | 1613664 | 1616135 | (2471) | -0.2% | 3133088 | 3113358 | 19730 | 0.6% |
| &nbsp;&nbsp;&nbsp;Depreciation and amortization | 6342 | 4260 | 2082 | 48.9% | 12154 | 7156 | 4998 | 69.8% |
| &nbsp;&nbsp;&nbsp;Stock-based compensation | 608703 | 300539 | 308164 | 102.5% | 784064 | 471649 | 312415 | 66.2% |
| &nbsp;&nbsp;&nbsp;Foreign currency translation loss (gain) | (84179) | 11982 | (96161) | NM | (11663) | 23225 | (34888) | NM |
| Total Operating Expenses | 3733270 | 3319509 | 413761 | 12.5% | 6902889 | 6346392 | 556497 | 8.8% |
| Income (loss) from operations | (329443) | (481849) | 152406 | 31.6% | (149814) | (848357) | 698544 | 82.3% |
| Other Income (Expenses): |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Other income (expense) | 74695 | 264 | 74431 | NM | 113764 | 540 | 113224 | NM |
| &nbsp;&nbsp;&nbsp;Provision for income taxes | (782) |  | (782) | NM | (4915) | (5770) | 855 | 14.8% |
| &nbsp;&nbsp;&nbsp;Gain on sale of disc'd operations | - | - | - |  | - | - | - |  |
| Total Other Income (Expenses): | 73913 | 264 | 73649 | NM | 108849 | (5230) | 114079 | NM |
| Net income (loss) | $(255530) | $(481585) | 226055 | 46.9% | $(40965) | $(853587) | 812623 | 95.2% |
|  |  |  |  | NM |  |  |  | NM |
| Adjusted EBITDA | $201423 | $(165068) | $366491 | NM | $634741 | $(346327) | $981069 | NM |

---

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **Quarter Ended December 31,** | **Quarter Ended December 31,** | **Quarter Ended December 31,** | **Quarter Ended December 31,** | **Six Months Ended December 31,** | **Six Months Ended December 31,** | **Six Months Ended December 31,** | **Six Months Ended December 31,** |
|  | **2022** | **2021** | **Change** | **% Change** | **2022** | **2021** | **Change** | **% Change** |
| **Platforms:** |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;ARR (Annual recurring revenue): |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Beginning of Period | $8331770 | $6282927 | $2048843 | 32.6% | $7922188 | $5880179 | $2042009 | 34.7% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Incremental ARR | 445207 | 565687 | (120480) | -21.3% | 854789 | 968434 | (113646) | -11.7% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;End of Period | $8776977 | $6848613 | $1928363 | 28.2% | $8776977 | $6848613 | $1928363 | 28.2% |
| &nbsp;&nbsp;&nbsp;Deployments: |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Beginning of Period | 756 | 590 | 166 | 28.1% | 733 | 553 | 180 | 32.5% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Incremental Deployments | 34 | 56 | (22) | -39.3% | 57 | 93 | (36) | -38.7% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;End of Period | 790 | 646 | 144 | 22.3% | 790 | 646 | 144 | 22.3% |
| &nbsp;&nbsp;&nbsp;ASP (Average sales price): |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Beginning of Period | $11021 | $10649 | $372 | 3.5% | $10808 | $10633 | $175 | 1.6% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;End of Period | $11110 | $10602 | $509 | 4.8% | $11110 | $10602 | $509 | 4.8% |
| **Transaction Customers:** |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Corporate customers | 921 | 867 | 54 | 6.2% | 922 | 860 | 62 | 7.2% |
| &nbsp;&nbsp;&nbsp;Academic customers | 302 | 312 | (10) | -3.2% | 300 | 306 | (6) | -2.0% |
| &nbsp;&nbsp;&nbsp;Total customers | 1223 | 1179 | 44 | 3.7% | 1222 | 1166 | 56 | 4.8% |

---

**Active Customer Accounts, Transactions and Annual Recurring Revenue**

The company defines active customer accounts as the sum of the total quantity of customers per month for each month in the period divided by the respective number of months in the period. The quantity of customers per month is defined as customers with at least one transaction during the month.

A transaction is an order for a unit of copyrighted content fulfilled or managed in the Platform.

The company defines annual recurring revenue ("ARR") as the value of contracted Platform subscription recurring revenue normalized to a one-year period.

**Use of Non-GAAP Measure – Adjusted EBITDA**

Research Solutions' management evaluates and makes operating decisions using various financial metrics. In addition to the company's GAAP results, management also considers the non-GAAP measure of Adjusted EBITDA. Management believes that this non-GAAP measure provides useful information about the company's operating results.

The tables below provide a reconciliation of this non-GAAP financial measure with the most directly comparable GAAP financial measure. Adjusted EBITDA is defined as net income (loss), plus interest expense, other income (expense), foreign currency transaction loss, provision for income taxes, depreciation and amortization, stock-based compensation, gain on sale of discontinued operations, and other potential adjustments that may arise. Set forth below is a reconciliation of Adjusted EBITDA to net income (loss):

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **Quarter Ended December 31,** | **Quarter Ended December 31,** | **Quarter Ended December 31,** | **Quarter Ended December 31,** | **Six Months Ended December 31,** | **Six Months Ended December 31,** | **Six Months Ended December 31,** | **Six Months Ended December 31,** |
|  | **2022** | **2021** | **Change** | **% Change** | **2022** | **2021** | **Change** | **% Change** |
| **Net Income (loss)** | $(255530) | $(481585) | $226055 | 46.9% | $(40965) | $(853587) | $812623 | 95.2% |
| Add (deduct): |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Other income (expense) | (74695) | (264) | (74431) | NM | (113764) | (540) | (113224) | NM |
| &nbsp;&nbsp;&nbsp;Foreign currency translation loss (gain) | (84179) | 11982 | (96161) | -802.5% | (11663) | 23225 | (34888) | -150.2% |
| &nbsp;&nbsp;&nbsp;Provision for income taxes | 782 |  | 782 | NM | 4915 | 5770 | (855) | -14.8% |
| &nbsp;&nbsp;&nbsp;Depreciation and amortization | 6342 | 4260 | 2082 | 48.9% | 12154 | 7156 | 4998 | 69.8% |
| &nbsp;&nbsp;&nbsp;Stock-based compensation | 608703 | 300539 | 308164 | 102.5% | 784064 | 471649 | 312415 | 66.2% |
| &nbsp;&nbsp;&nbsp;Gain on sale of disc. ops. | - | - | - |  | - | - | - |  |
| Adjusted EBITDA | $201423 | $(165068) | $366491 | NM | $634741 | $(346327) | $981069 | NM |

---

**About Research Solutions** 

Research Solutions, Inc. (NASDAQ: RSSS) provides cloud-based technologies to streamline the process of obtaining, managing, and creating intellectual property. Founded in 2006 as Reprints Desk, the company was a pioneer in developing solutions to serve researchers. Today, more than 70 percent of the top pharmaceutical companies, prestigious universities, and emerging businesses rely on Article Galaxy, the company's SaaS research platform, to streamline access to the latest scientific research and data with 24/7 customer support. For more information and details, please visit**www.researchsolutions.com** and **www.reprintsdesk.com**

**Important Cautions Regarding Forward-Looking Statements**

Certain statements in this press release may contain "forward-looking statements" regarding future events and our future results. All statements other than statements of historical facts are statements that could be deemed to be forward-looking statements. These statements are based on current expectations, estimates, forecasts, and projections about the markets in which we operate and the beliefs and assumptions of our management. Words such as "expects," "anticipates," "targets," "goals," "projects", "intends," "plans," "believes," "seeks," "estimates," "endeavors," "strives," "may," or variations of such words, and similar expressions are intended to identify such forward-looking statements. Readers are cautioned that these forward-looking statements are subject to a number of risks, uncertainties and assumptions that are difficult to predict, estimate or verify. Therefore, actual results may differ materially and adversely from those expressed in any forward-looking statements. Such risks and uncertainties include those factors described in the Company's most recent annual report on Form 10-K, as such may be amended or supplemented by subsequent quarterly reports on Form 10-Q, or other reports filed with the Securities and Exchange Commission. Examples of forward-looking statements in this release include statements regarding additional customers, potential acquisitions and the Company's prospects for growth. Readers are cautioned not to place undue reliance on these forward-looking statements. The forward-looking statements are made only as of the date hereof, and the Company undertakes no obligation to publicly release the result of any revisions to these forward-looking statements. For more information, please refer to the Company's filings with the Securities and Exchange Commission.

**Research Solutions, Inc. and Subsidiaries**

**Consolidated Balance Sheets**

---

| | | |
|:---|:---|:---|
|  | **December 31,**<br>**2022**<br>(unaudited) |<br>**June 30,**<br>**2022** |
| **Assets** |  |  |
| **Current assets:** |  |  |
| &nbsp;&nbsp;Cash and cash equivalents | $11262564 | $10603175 |
| &nbsp;&nbsp;Accounts receivable, net of allowance of $71,019 and $94,144, respectively | 5243386 | 5251545 |
| &nbsp;&nbsp;Prepaid expenses and other current assets | 343629 | 276026 |
| &nbsp;&nbsp;Prepaid royalties | 41216 | 846652 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total current assets | 16890795 | 16977398 |
| **Other assets:** |  |  |
| &nbsp;&nbsp;Property and equipment, net of accumulated depreciation of $855,494 and $840,996, respectively | 55165 | 47985 |
| &nbsp;&nbsp;Non-refundable deposit for asset acquisition | 297450 |  |
| &nbsp;&nbsp;Deposits and other assets | 924 | 893 |
| **Total assets** | $17244334 | $17026276 |
| **Liabilities and Stockholders' Equity** |  |  |
| **Current liabilities:** |  |  |
| &nbsp;&nbsp;Accounts payable and accrued expenses | $5629101 | $6604032 |
| &nbsp;&nbsp;Deferred revenue | 5967525 | 5538526 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total current liabilities | 11596626 | 12142558 |
| **Commitments and contingencies** |  |  |
| **Stockholders' equity:** |  |  |
| &nbsp;&nbsp;Preferred stock; $0.001 par value; 20,000,000 shares authorized; no shares issued and outstanding |  |  |
| &nbsp;&nbsp;Common stock; $0.001 par value; 100,000,000 shares authorized; 29,154,737 and 27,075,648 shares issued and outstanding, respectively | 29155 | 27076 |
| &nbsp;&nbsp;Additional paid-in capital | 28874383 | 28072855 |
| &nbsp;&nbsp;Accumulated deficit | (23135237) | (23094272) |
| &nbsp;&nbsp;Accumulated other comprehensive loss | (120593) | (121941) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total stockholders' equity | 5647708 | 4883718 |
| **Total liabilities and stockholders' equity** | $17244334 | $17026276 |

---

**Research Solutions, Inc. and Subsidiaries**

**Consolidated Statements of Operations and Other Comprehensive Loss**

**(Unaudited)**

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Three Months Ended** | **Three Months Ended** | **Six Months Ended** | **Six Months Ended** |
|  | **December 31,** | **December 31,** | **December 31,** | **December 31,** |
|  | **2022** | **2021** | **2022** | **2021** |
| Revenue: |  |  |  |  |
| &nbsp;&nbsp;Platforms | $2110272 | $1604829 | $4130239 | $3114703 |
| &nbsp;&nbsp;Transactions | 6606394 | 6267458 | 13271070 | 12500088 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total revenue | 8716666 | 7872287 | 17401309 | 15614791 |
| Cost of revenue: |  |  |  |  |
| &nbsp;&nbsp;Platforms | 253073 | 231668 | 483546 | 477324 |
| &nbsp;&nbsp;Transactions | 5059766 | 4802959 | 10164688 | 9639432 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total cost of revenue | 5312839 | 5034627 | 10648234 | 10116756 |
| Gross profit | 3403827 | 2837660 | 6753075 | 5498035 |
| **Operating expenses:** |  |  |  |  |
| &nbsp;&nbsp;Selling, general and administrative | 3726928 | 3315249 | 6890735 | 6339236 |
| &nbsp;&nbsp;Depreciation and amortization | 6342 | 4260 | 12154 | 7156 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total operating expenses | 3733270 | 3319509 | 6902889 | 6346392 |
| Loss from operations | (329443) | (481849) | (149814) | (848357) |
| &nbsp;&nbsp;Other income | 74695 | 264 | 113764 | 540 |
| Loss from operations before provision for income taxes | (254748) | (481585) | (36050) | (847817) |
| Provision for income taxes | (782) |  | (4915) | (5770) |
| Net loss | (255530) | (481585) | (40965) | (853587) |
| **Other comprehensive income (loss):** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Foreign currency translation | 6524 | 185 | 1348 | (2790) |
| Comprehensive loss | $(249006) | $(481400) | $(39617) | $(856377) |
| Loss per common share: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Net loss per share, basic and diluted | $(0.01) | $(0.02) | $- | $(0.03) |
| &nbsp;&nbsp;&nbsp;&nbsp;Weighted average common shares outstanding, basic and diluted | 26816550 | 26351947 | 26767360 | 26314532 |

---

**Research Solutions, Inc. and Subsidiaries**

**Consolidated Statements of Cash Flows**

**(Unaudited)**

---

| | | |
|:---|:---|:---|
|  | **Six Months Ended** | **Six Months Ended** |
|  | **December 31,** | **December 31,** |
|  | **2022** | **2021** |
| **Cash flow from operating activities:** |  |  |
| &nbsp;&nbsp;Net loss | $(40965) | $(853587) |
| &nbsp;&nbsp;Adjustment to reconcile net loss to net cash provided by (used in) operating activities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Depreciation and amortization | 12154 | 7156 |
| &nbsp;&nbsp;&nbsp;&nbsp;Fair value of vested stock options | 301737 | 127668 |
| &nbsp;&nbsp;&nbsp;&nbsp;Fair value of vested restricted common stock | 482327 | 343981 |
| &nbsp;&nbsp;&nbsp;&nbsp;Fair value of vested unrestricted common stock | 68272 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Changes in operating assets and liabilities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounts receivable | 8159 | 99113 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Prepaid expenses and other current assets | (67603) | (55609) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Prepaid royalties | 805436 | 249775 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounts payable and accrued expenses | (974931) | (172283) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Deferred revenue | 428999 | (63113) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net cash provided by (used in) operating activities | 1023585 | (316899) |
| **Cash flow from investing activities:** |  |  |
| &nbsp;&nbsp;Purchase of property and equipment | (18876) | (26991) |
| &nbsp;&nbsp;Payment for non-refundable deposit for asset acquisition | (297450) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net cash used in investing activities | (316326) | (26991) |
| **Cash flow from financing activities:** |  |  |
| &nbsp;&nbsp;Proceeds from the exercise of stock options |  | 30671 |
| &nbsp;&nbsp;Proceeds from the exercise of warrants |  | 59500 |
| &nbsp;&nbsp;Common stock repurchase | (48729) | (67812) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net cash provided by (used in) financing activities | (48729) | 22359 |
| Effect of exchange rate changes | 859 | (3092) |
| Net increase (decrease) in cash and cash equivalents | 659389 | (324623) |
| Cash and cash equivalents, beginning of period | 10603175 | 11004337 |
| Cash and cash equivalents, end of period | $11262564 | $10679714 |
| **Supplemental disclosures of cash flow information:** |  |  |
| &nbsp;&nbsp;Cash paid for income taxes | $4915 | $5770 |

---

**Contact**

Steven Hooser or John Beisler

Three Part Advisors

(214) 872-2710

<u>shooser@threepa.com</u>; <u>jbeisler@threepa.com</u>

# # #